BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| 2,3-Dihydro-2-thioxo-1-(2,3,5-tri-O-acetyl-α-D-ribofuranosyl)-4(1H)-pyrimidinone | 2,3-Dihydro-2-thioxo-1-(2,3,5-tri-O-acetyl-α-D-ribofuranosyl)-4(1H)-pyrimidinone is an intermediate in the synthesis of 2,4-Dithiouridine. Molecular formula: C15H18N2O8S. Mole weight: 386.38. |  |
| 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin | 2,3-Dimethyl-6-amino-6-deoxy-gamma-cyclodextrin is a chemically modified cyclodextrin, vital in pharmaceutical applications. Its significant role lies in improving bioavailability and stability of drugs, particularly ones with low solubility. Additionally, it shows promise in cargo delivery for gene therapy. Alternative Names: Octakis-(2,3-di-O-methyl-6-amino-6-deoxy)-γ-cyclodextrin. Molecular formula: C64H120N8O32. Mole weight: 1513.67. | |
| 2,3-dimethyl-6-deoxy-gamma-cyclodextrin | 2,3-dimethyl-6-deoxy-gamma-cyclodextrin is a pharmaceutical catalyst, magnifing drug solvency and stability masterfully. Alternative Names: Octakis-(2,3-di-O-methyl-6-deoxy)-γ-cyclodextrin. Molecular formula: C64H112O32. Mole weight: 1393.55. | |
| 2,3-Dimethyl-6-tert-butyldimethylsilyl-a-cyclodextrin | 2,3-Dimethyl-6-tert-butyldimethylsilyl-a-cyclodextrin is a medicinal chemistry tool, extensively used in the formulation of water-insoluble drugs. It boosts drug solubility and stability, enhancing bioavailability, primarily found beneficial within cancer research. Alternative Names: Hexakis-(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-a-cyclodextrin. Molecular formula: C84H168O30Si6. Mole weight: 1826.73. | |
| 2,3-Dimethyl-a-cyclodextrin | 2,3-Dimethyl-a-cyclodextrin is a derivative of cyclodextrin, engaged in the pharmaceutical domain as an operative system for drug conveyance. Through augmentation of both solubility and durability of pharmacological agents, it facilitates enhanced medication administration and efficiency. Alternative Names: Hexakis-(2,3-di-O-methyl)-a-cyclodextrin. Molecular formula: C48H84O30. Mole weight: 1141.16. | |
| 2,3-Dimethyl-b-cyclodextrin | 2,3-Dimethyl-b-cyclodextrin is a modified cyclodextrin derivative, used primarily in enhancing drug solubility for therapeutics with low water-solubility. It's often utilized in theresearch of diseases requiring complex medication formulations. Alternative Names: Heptakis(2,3-di-O-methyl)-b-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradeca-O-methyl-β-cyclodextrin; 2,3-Dimethyl-β-cyclodextrin; 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradecamethoxy-β-cyclodextrin; Heptakis(2,3-di-O-methyl)-β-cyclodextrin; Heptakis(2,3-dimethyl)-β-cyclodextrin; 2,3-DMe-beta-cyclodextrin. CAS No. 123155-05-5. Molecular formula: C56H98O35. Mole weight: 1331.36. | |
| 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt | 2,3-Dimethyl-cyclodextrin-6-hydrogen sulfate, sodium salt, a remarkably versatile compound extensively employed in the field of biomedical research, represents a paramount breakthrough. In its pivotal role as a complexing agent, it unfailingly amplifies the solubility and durability of an array of pharmaceutical compounds. This extraordinary product exhibits unparalleled efficacy when employed in the formulation of drug delivery mechanisms designed to tackle a multitude of debilitating ailments, including but not limited to cancer, cardiovascular afflictions, and neurologic disorders. Alternative Names: Heptakis(2,3-di-O-methyl-6-O-sulfo)-b-cyclodextrin heptasodium salt; β-Cyclodextrin, 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-tetradeca-O-methyl-, 6A,6B,6C,6D,6E,6F,6G-heptakis(hydrogen sulfate), sodium salt (1:7); 2A,2B,2C,2D,2E,2F,2G,3A,3B,3C,3D,3E,3F,3G-Tetradeca-O-methyl-β-cyclodextrin, heptakis(hydrogen sulfate), heptasodium salt; Heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin sodium salt; Heptakis(2,3-dimethyl-6-sulfato)-β-cyclodextrin sodium salt; Sodium heptakis(2,3-dimethyl-6-sulfato)-β-cyclodextrin. CAS No. 201346-23-8. Molecular formula: C56H91Na7O56S7. Mole weight: 2045.64. | |
| 2,3-Dimethyl-gamma-cyclodextrin | 2,3-Dimethyl-gamma-cyclodextrin is an omnipotent solubilizing entity, escalating the equilibrium and robustness of pharmaceutical compounds. Concurrently, it contributes to amplifying bioavailability in drugs exhibiting suboptimal solubility. Alternative Names: Octakis-(2,3-di-O-methyl)-γ-cyclodextrin. Molecular formula: C64H112O40. Mole weight: 1521.55. | |
| 2,3-di-O-[(4-Methoxyphenyl)methyl]-4,6-O-[phenylmethylene]-α-D-galactopyranosyl fluoride | 2,3-di-O-[(4-Methoxyphenyl)methyl]-4,6-O-[phenylmethylene]-α-D-galactopyranosyl fluoride. Alternative Names: 1-Deoxy-1-fluoro-4,6-O-Benzylidene-2,3-di-O-(4-methoxybenzyl)-α-D-galactopyranoside; 2,3-di-O-(4-methoxybenzyl)-4,6-O-[phenylmethylene]-α-D-galactopyranosyl fluoride. Molecular formula: C29H31FO7. Mole weight: 510.56. | |
| 2,3-Di-O-acetyl-4,6-dideoxy-a-D-glucopyranosyl trichloroacetimidate | 2,3-Di-O-acetyl-4,6-dideoxy-a-D-glucopyranosyl trichloroacetimidate, an essential chemical reagent in oligosaccharide synthesis, serves as a tool for elucidating the significance of carbohydrates in biological pathways with implications in pharmaceutical innovations to combat fatal ailments like cancer and diabetes. This compound finds extensive employment in the biomedical sector to extrapolate and investigate the diverse phenomena of carbohydrate metabolism and contribute to significant advancements in drug development. Its indispensability is owing to its optimal burstiness in the chemical realm. CAS No. 485809-87-8. Molecular formula: C12H16Cl3NO6. Mole weight: 376.62. | |
| 2,3-Di-O-acetyl-4,6-O-benzylidene-N-Cbz-1-deoxynojirimycin | 2,3-Di-O-acetyl-4,6-O-benzylidene-N-Cbz-1-deoxynojirimycin. Alternative Names: N-Benzyloxycarbonyl-4,6-O-phenylmethylene DNJ 2,3-diacetate; (4aR,7S,8R,8aR)-7,8-bis(Acetyloxy)hexahydro-2-phenyl-5H-1,3-dioxino[5,4-b]pyridine-5-carboxylic acid phenylmethyl ester. CAS No. 2124269-54-9. Molecular formula: C25H27NO8. Mole weight: 469.49. | |
| 2',3'-Di-O-acetyl-4-N-benzoylcytidine | 2',3'-Di-O-acetyl-4-N-benzoylcytidine is a potent antiviral precursor. With a primary function specifically aligned towards the inhibition of HIV-1 reverse transcriptase, it effectively acts as an impediment in the intricate labyrinth of the HIV replication process. Alternative Names: Cytidine, N-benzoyl-, 2',3'-diacetate; N-Benzoyl-2'-O,3'-O-diacetylcytidine; (2R,3R,4R,5R)-2-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl diacetate. CAS No. 99519-17-2. Molecular formula: C20H21N3O8. Mole weight: 431.40. | |
| 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine | A protected cytidine derivative. Alternative Names: 5'-Deoxy-5-fluoro-N-[(2-methylbutoxy)carbonyl]cytidine 2',3'-Diacetate. Grades: 97%. CAS No. 1341231-51-3. Molecular formula: C19H26FN3O8. Mole weight: 443.42. | |
| 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine | A protected cytidine derivative. Alternative Names: 5'-Deoxy-5-fluoro-N-[(3-methylbutoxy)carbonyl]cytidine 2',3'-Diacetate; [1-(2,3-Di-O-acetyl-5-deoxy-β-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic Acid 3-Methylbutyl Ester. Grades: 96%. CAS No. 162204-22-0. Molecular formula: C19H26FN3O8. Mole weight: 443.42. | |
| 2',3'-Di-O-acetyl-5'-deoxy-5-nitro-N4-(pentyloxycarbonyl)cytidine | 2',3'-Di-O-acetyl-5'-deoxy-5-nitro-N4-(pentyloxycarbonyl)cytidine is precursor in the development of formidable antiviral drugs, remarkably those targeting HIV. Alternative Names: 2',3'-Di-O-acetyl-5'-deoxy-5-nitro-N-[(pentyloxy)carbonyl]cytidine. Grades: 95%. CAS No. 865474-03-9. Molecular formula: C19H26N4O10. Mole weight: 470.43. | |
| 2',3'-Di-O-acetyl-5'-O-DMT-5-methyluridine | 2',3'-Di-O-acetyl-5'-O-DMT-5-methyluridine is a vital compound used in the biomedicine industry for various applications. This product is primarily employed in the synthesis of nucleoside analogs used for viral and cancer research. It exhibits potential antiviral activity against certain viral diseases and can aid in the development of novel therapeutic treatments. | |
| 2,3-Di-O-acetyl-6-deoxy-gamma-cyclodextrin | 2,3-Di-O-acetyl-6-deoxy-gamma-cyclodextrin is a type of cyclodextrin widely used in the pharmaceutical industry. It serves as a stabilizer and solubilizing agent for poorly soluble drugs, as well as a delivery system for various bioactive agents. This product has been studied for its potential use in treating various diseases, including cancer and Alzheimer's disease. Alternative Names: Octakis-(2,3-di-O-acetyl-6-deoxy)-γ-cyclodextrin. Molecular formula: C80H112O48. Mole weight: 1841.72. | |
| 2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is a modified cyclodextrin used in enhancing the solubility and stability of drugs, improving their bioavailability. It is often employed in developing formulations for poorly soluble drugs. Alternative Names: Octakis-(2,3-di-O-acetyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C12H224O56SI8. Mole weight: 2313.18. | |
| 2,3-Di-O-acetyl-a-cyclodextrin | 2,3-Di-O-acetyl-a-cyclodextrin is mainly used to increase the solubility and stability of drugs. Its specialized structure is capable of forming inclusion complexes with various compounds, enhancing their bioavailability. Notably applied in the design of improved drug delivery systems. Alternative Names: Hexakis-(2,3-di-O-acetyl)-a-cyclodextrin. Molecular formula: C60H84O42. Mole weight: 1477.28. | |
| 2',3'-Di-O-acetyladenoside | 2',3'-Di-O-acetyladenoside is a modified nucleoside frequently used in the biomedicine industry. It offers potential as a therapeutic agent in the research of viral diseases and cancers by inhibiting the functions of certain proteins and enzymes. Alternative Names: 2',3'-DI-O-ACETYLADENOSINE;Adenosine,2',3'-diacetate; (2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl diacetate; 9-(2,3-di-O-acetylpentofuranosyl)-9H-purin-6-amine. Grades: 95% (HPLC). CAS No. 29886-19-9. Molecular formula: C14H17N5O6. Mole weight: 351.31. | |
| 2,3-Di-O-acetyl-b-cyclodextrin | 2,3-Di-O-acetyl-b-cyclodextrin is a derivative of beta-cyclodextrin, used in the biomedical industry for drug delivery systems. It enhances the soluble property of poorly water-soluble drugs, aiding in their absorption and distribution. Alternative Names: Heptakis-(2,3-di-O-acetyl)-b-cyclodextrin. Molecular formula: C70H98O49. Mole weight: 1723.50. | |
| 2,3-Di-O-acetyl-gamma-cyclodextrin | 2,3-Di-O-acetyl-gamma-cyclodextrin, an invaluable compound, finds extensive application in the biomedical industry. Its role lies in elevating the solubility and stability of drugs, rendering it indispensable in pharmaceutical formulations. By virtue of its exceptional encapsulation capabilities, it facilitates enhanced drug delivery systems and targeted therapy. Alternative Names: Octakis-(2,3-di-O-acetyl)-γ-cyclodextrin. Molecular formula: C80H112O56. Mole weight: 1969.71. | |
| 2,3-Di-O-allyl-a-cyclodextrin | 2,3-Di-O-allyl-a-cyclodextrin is a biomedical substance used in drug delivery due to its exceptional encapsulation capability. It's primarily utilized in the formulation of hydrophobic drugs, improving their solubility and bioavailability, thus enhancing therapeutic effectiveness. Alternative Names: Hexakis-(2,3-di-O-allyl)-a-cyclodextrin. Molecular formula: C72H108O30. Mole weight: 1453.61. | |
| 2,3-Di-O-allyl-b-cyclodextrin | 2,3-Di-O-allyl-b-cyclodextrin is a modified cyclodextrin used to enhance drug delivery. It's primarily used in pharmaceuticals to improve solubility and stability of poorly soluble drugs, facilitating more efficient drug absorption and increasing their therapeutic efficacy. Alternative Names: Heptakis-(2,3-di-O-allyl)-b-cyclodextrin. Molecular formula: C84H126O35. Mole weight: 1695.88. | |
| 2,3-Di-O-benzoyl-a-cyclodextrin | 2,3-Di-O-benzoyl-a-cyclodextrin is a pharmaceutical excipient often used in drug formulation. It enhances the solubility of poorly water-soluble drugs, improving their effectiveness and bioavailability. It is used widely in the research of various diseases. CAS No. 68715-47-9. Molecular formula: C120H108O42. Mole weight: 2222.12. | |
| 2,3-Di-O-benzoyl-L-threonic acid-1,4-lactone | 2,3-Di-O-benzoyl-L-threonic acid-1,4-lactone, a chemical entity exhibiting potent antiviral efficacy against the hepatitis B virus, has garnered substantial scientific attention in recent years due to its remarkable potential in inhibiting tumour progression and metastasis. Molecular formula: C18H14O6. Mole weight: 326.30. | |
| 2',3'-Di-O-benzoyl-N6-benzoyl-L-adenosine | 2',3'-Di-O-benzoyl-N6-benzoyl-L-adenosine, a specialized compound extensively employed in the biomedical sector, demonstrates tremendous promise as an antiviral entity, effectively combatting a wide array of ailments induced by viral invasions. Remarkably efficient in impeding the replication of specific viruses, this remarkable agent exhibits immense potential for advancing the realm of antiviral therapeutics and pharmaceutical interventions. Alternative Names: Benzamide, N-[9-(2,3-di-O-benzoyl-β-L-ribofuranosyl)-9H-purin-6-yl]-; N-[9-(2,3-Di-O-benzoyl-β-L-ribofuranosyl)-9H-purin-6-yl]benzamide; N6,2',3'-O-tribenzoyl-L-adenosine; N6-benzoyl-9-(2',3'-di-O-benzoyl-β-L-ribofuranosyl)adenine; (2S,3S,4S,5S)-2-(6-benzamido-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl dibenzoate. CAS No. 200562-12-5. Molecular formula: C31H25N5O7. Mole weight: 579.56. | |
| 2',3'-Di-O-benzoyluridine | 2',3'-Di-O-benzoyluridine is a pyrimidine nucleoside derivative, instrumental in the synthesis of selected antiviral medications. Predominantly, it is utilized in research of targeting Hepatitis B. Additionally, it holds latent capacities for deployment in analyzing ribonucleotide reductase inhibitors' practicalities and performances. Alternative Names: 2',3'-O-dibenzoyluridine; 2',3'-dibenzoyluridine; 2',3'-di-O-benzoyluridine; uridine 2',3'-dibenzoate; 1-(2,3-Di-O-benzoylpentofuranosyl)-4-hydroxypyrimidin-2(1H)-one; (2R,3R,4R,5R)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diyl dibenzoate. Grades: 95%. CAS No. 50408-20-3. Molecular formula: C23H20N2O8. Mole weight: 452.41. | |
| 2,3-Di-O-benzyl-4,6-O-ethylidene-D-glucopyranose | 2,3-Di-O-benzyl-4,6-O-ethylidene-D-glucopyranose, an esteemed compound of immense significance in the realm of biomedicine, has garnered attention due to its inherent potential for multifaceted applications. Widely employed in the synthesis of pharmaceutical drugs, this compound holds immense promise in combating a diverse array of ailments. Alternative Names: D-Glucopyranose, 4,6-O-(1R)-ethylidene-2,3-bis-O-(phenylmethyl)-. CAS No. 471863-88-4. Molecular formula: C22H26O6. Mole weight: 386.44. | |
| 2,3-Di-O-benzyl-4-deoxy-L-fucose | 2,3-Di-O-benzyl-4-deoxy-L-fucose is a vital component in the biomedical industry. Its applications include its use in the synthesis of potential antitumor drug derivatives and the treatment of various diseases related to irregular glycogen metabolism. Alternative Names: 2,3-Di-O-benzyl-4,6-dideoxy-L-xylo-hexose. CAS No. 191036-43-8. Molecular formula: C20H24O4. Mole weight: 328.40. | |
| 2,3-Di-O-benzyl-5-O-tert-butyldimethylsilyl-D-xylofuranose | 2,3-Di-O-benzyl-5-O-tert-butyldimethylsilyl-D-xylofuranose, a prominent chemical compound in the biomedicine industry, showcases its potential in contributing to antiviral and antibacterial drug discovery. Focusing on its importance in carbohydrate chemistry, this compound notably participates in the synthesis of complex carbohydrates and glycoconjugates, with extensive requirements in various fields. Molecular formula: C25H36O5Si. Mole weight: 444.65. | |
| 2,3-Di-O-benzyl-5-O-tert-butyldimethylsilyl-L-arabinofuranose | 2,3-Di-O-benzyl-5-O-tert-butyldimethylsilyl-L-arabinofuranose, an organic compound with a benzylated arabinose moiety, exhibits significant potency as a key intermediate in the synthesis of antiviral and antitumor agents. This chemical entity has garnered interest for its prospective therapeutic application in humans, particularly in combating HIV and cancer. Its unique molecular configuration yields an arsenal of reactive sites, enabling it to participate in various chemical reactions, and thereby augmenting its potential for use in medicinal chemistry. Molecular formula: C25H36O5Si. Mole weight: 444.65. | |
| 2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is a modified cyclodextrin used in the formation of complex structures for the delivery of various drugs. Specifically, it assists in improving the solubility and bioavailability of poorly soluble pharmaceuticals. Alternative Names: Octakis-(2,3-di-O-benzyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C208H288O40SI8. Mole weight: 4475.79. | |
| 2,3-Di-O-benzyl-a-cyclodextrin | 2,3-Di-O-benzyl-a-cyclodextrin is a versatile carrier for various drugs due to its unique structure. It is utilized in designing drug delivery systems and enhancing solubility of poorly soluble drugs, thereby improving their bioavailability. Alternative Names: Hexakis-(2,3-di-O-benzyl)-a-cyclodextrin. Molecular formula: C120H132O30. Mole weight: 2054.31. | |
| 2,3-Di-O-benzyl-b-cyclodextrin | 2,3-Di-O-benzyl-b-cyclodextrin is a modified cyclodextrin primarily used in the pharmaceutical industry. Its unique structure increases drug solubility and stability. Alternative Names: Heptakis-(2,3-di-O-benzyl)-b-cyclodextrin. Molecular formula: C140H154O35. Mole weight: 2396.70. | |
| 2,3-Di-O-benzyl-D-glucopyranose | 2,3-Di-O-benzyl-D-glucopyranose, an indispensable element in biomedicine, finds its utilization in the synthesis of pharmaceuticals and the exploration of carbohydrates. Its presence significantly contributes to the advancement of drug development, targeting afflictions such as diabetes, obesity, and cancer. Alternative Names: (3R,4S,5R,6R)-3,4-Bis(benzyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,5-diol. CAS No. 18933-71-6. Molecular formula: C20H24O6. Mole weight: 360.40. | |
| 2,3-Di-O-benzyl-L-threonic acid-1,4-lactone | 2,3-Di-O-benzyl-L-threonic acid-1,4-lactone, a chemical utilized in the biomedicine sector for its potent antioxidant proficiency, exhibits favorable therapeutic effects with respect to ameliorating oxidative stress-induced ailments, including cardiovascular diseases and carcinogenesis. Despite its proven efficacy, it is still fundamental to ascertain its modus operandi, alongside its potential clinical applications, thereby necessitating further investigation. CAS No. 150575-74-9. Molecular formula: C18H18O4. Mole weight: 298.33. | |
| 2,3-Di-O-Carboxymethyl-D-glucose | 2,3-Di-O-Carboxymethyl-D-glucose is a pharmacologic substance utilized in the remediation of pathophysiological conditions arising from impaired glucose metabolism. Its mechanism of action lies in suppressing the enzymatic activities involved in carbohydrate catabolism. Its medical usage is mostly directed towards the management of diabetes mellitus and other associated metabolic abnormalities. Notably, it can also function as a diagnostic tool for specific clinical investigations. Alternative Names: [(2R,3R,4S,5R)-5-carboxyoxy-1,2,3-trihydroxy-6-oxoheptan-4-yl] hydrogen carbonate. CAS No. 95350-41-7. Molecular formula: C10H16O10. Mole weight: 296.23. | |
| 2',3'-Di-O-isopropylidene-2-thiouridine | 2',3'-Di-O-isopropylidene-2-thiouridine, a modified nucleoside, is widely utilized during RNA synthesis due to its capacity to boost stability and specificity. Its versatility extends to therapeutic arenas such as antisense therapy and RNA interference, with potential use against viral infections and cancer demonstrated during studies. Alternative Names: 2',3'-O-Isopropylidene-2-thiouridine; Uridine, 2',3'-O-(1-methylethylidene)-2-thio-; O2',O3'-isopropylidene-2-thio-uridine; 4-Hydroxy-1-((3aR,4R,6R,6aR)-6-hydroxymethyl-2,2-dimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-yl)-1H-pyrimidine-2-thione; 1-(2,3-O-Isopropylidene-β-L-xylofuranosyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone. Grades: ≥95%. CAS No. 6984-55-0. Molecular formula: C12H16N2O5S. Mole weight: 300.33. | |
| 2',3'-Di-O-isopropylidene-4'-alpha-azido-uridine | 2',3'-Di-O-isopropylidene-4'-alpha-azido-uridine, a nucleoside analog, has emerged as a potent weapon in the war against viral infections. It has exhibited remarkable inhibitory activity against hepatitis B and C, as well as HIV. Acting as an effective antiviral agent, this product exerts its action by disrupting essential steps in the viral life cycle. Its remarkable structural properties render it an indispensable tool in the fight against these scourges of humanity. Alternative Names: 2',3'-O-Isopropylidene-4'-Alpha-Azido-Uridine; 4'-C-Azido-2',3'-O-(1-methylethylidene)uridine; 4'-azido-2',3'-O-isopropylidenyluridine-4'-azido-2',3'-O-isopropylidenyluridine; 2',3'-Di-O-isopropylidene-4'-α-C-azidouridine; 1-[(3aR,4R,6R,6aS)-6-Azido-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-2,4(1H,3H)-pyrimidinedione. Grades: ≥95%. CAS No. 690271-27-3. Molecular formula: C12H15N5O6. Mole weight: 325.28. | |
| 2',3'-Di-O-isopropylidene-5-hydroxymethyluridine | 2',3'-Di-O-isopropylidene-5-hydroxymethyluridine, a nucleoside analogue, has been widely utilized in biomedical research as a vital and consequential substrate for RNA polymerase. The paramountcy of this analog has been accentuated by its incumbent placement in oligonucleotides wherein its impact on RNA structure and function has been meticulously studied. The prospects of this compound have been extolled as it has been observed to proffer inhibitory effects on select viral strains, thereby enhancing its application in the treatment of viral diseases. Alternative Names: 5-(hydroxymethyl)-1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione; 2'-O,3'-O-Isopropylidene-5-(hydroxymethyl)uridine; 2',3'-O-Isopropylidene-5-hydroxymethyluridine; 5-Hydroxymethyl-2',3'-(di-O-isopropylidene)uridine; 5-(Hydroxymethyl)-2',3'-O-(1-methylethylidene)uridine; 5-(Hydroxymethyl)-2',3'-O-isopropylideneuridine. Grades: ≥95%. CAS No. 3816-77-1. Molecular formula: C13H18N2O7. Mole weight: 314.29. | |
| 2',3'-Di-O-isopropylidene-5'-O-tritylpseudoisocytidine | 2',3'-Di-O-isopropylidene-5'-O-tritylpseudoisocytidine is a biochemical that plays a critical role in the development and synthesis of antiviral drugs. Primarily used for research purposes, it acts as a precursor of nucleoside analogues in antiretroviral therapies to combat diseases such as HIV. Alternative Names: 5-(2,3-O-isopropylidene-5-O-trityl-D-ribofuranosyl)-isocytosine. Grades: ≥ 95%. CAS No. 57100-19-3. Molecular formula: C31H31N3O5. Mole weight: 525.60. | |
| 2',3'-Di-O-isopropylidene-5-pyrrolidinomethyl-2-thiouridine | 2',3'-Di-O-isopropylidene-5-pyrrolidinomethyl-2-thiouridine is a nucleoside analogue that displays remarkable antiviral efficacy against herpes simplex virus type 1, Epstein-Barr virus and cytomegalovirus. Furthermore, it has demonstrated immense potential as a treatment against a diverse repertoire of malignancies, ranging from hepatocellular carcinoma to leukemia. Through these multifaceted therapeutic benefits, 2',3'-Di-O-isopropylidene-5-pyrrolidinomethyl-2-thiouridine stands as a formidable weapon in the fight against a variety of diseases. Alternative Names: 1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)-5-(pyrrolidin-1-ylmethyl)-2-thioxo-2,3-dihydropyrimidin-4(1H)-one; 2',3'-o-isopropylidene-5-pyrrolidinomethyl-2-thiouridine; 2',3'-O-(1-Methylethylidene)-5-(1-pyrrolidinylmethyl)-2-thiouridine; 1-(2,3-O-Isopropylidene-β-D-ribofuranosyl)-5-(1-pyrrolidinylmethyl)-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone. Grades: ≥95%. CAS No. 89845-82-9. Molecular formula: C17H25N3O5S. Mole weight: 383.46. | |
| 2',3'-Di-O-isopropylidene-isocytidine | 2',3'-Di-O-isopropylidene-isocytidine is a efficacious antiviral compound, employed in the realm of biomedical science for research of combating diverse viral infections such as hepatitis B and hepatitis C. By virtue of its profound ability to impede viral replication and hamper the synthesis of viral RNA, this exceptional compound contributes to the development of antiviral therapeutic modalities. Alternative Names: 2'-O,3'-O-Isopropylideneisocytidine; 4(1H)-Pyrimidinone, 2-amino-1-[2,3-O-(1-methylethylidene)-beta-d-ribofuranosyl]-; 2-Amino-1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidin-4(1H)-one; 2-Amino-1-(2,3-O-isopropylidenepentofuranosyl)-4(1H)-pyrimidinone; 2',3'-Isopropylidene-isocytidine. Grades: ≥95%. CAS No. 5975-5-3. Molecular formula: C12H17N3O5. Mole weight: 283.28. | |
| 2,3-di-O-methyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin | 2,3-di-O-methyl-6-O-tert-butyldimethylsilyl-gamma-cyclodextrin is primarily utilized as a chiral selective medium in pharmaceutical research. It aids in the separation of drug stereoisomers, thereby optimizing therapeutic effectiveness and minimizing side effects. Alternative Names: Octakis-(2,3-di-O-methyl-6-O-tert-butyldimethylsilyl)-γ-cyclodextrin. Molecular formula: C112H224O40SI8. Mole weight: 3258.25. | |
| 2',3'-Di-O-methyladenosine | 2',3'-Di-O-methyladenosine, a compound of utmost importance, finds extensive utility in the biomedical field owing to its immense potential for therapeutic purposes. In the realm of disease management, particularly in cancer, neurodegenerative disorders, and viral infections, this product assumes a pivotal role. Its remarkable chemical composition and distinct pharmacological characteristics render it an exceedingly propitious contender for targeted pharmaceutical administration and individualized medical interventions. Alternative Names: 2',3'-O-Me-rA; Adenosine, 2',3'-di-O-methyl-; ((2R,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dimethoxytetrahydrofuran-2-yl)methanol; 2',3'-Dimethoxyadenosine. Grades: ≥98% by HPLC. CAS No. 20649-46-1. Molecular formula: C12H17N5O4. Mole weight: 295.29. | |
| 2,3-Di-O-methyl-D-glucopyranose | 2,3-Di-O-methyl-D-glucopyranose, a carbohydrate derivative, serves as a vital component in synthesising glycosylated molecules and is a fundamental starting material for producing glycosidase inhibitors. These are crucial therapeutic agents, catering to the likes of diabetes and cancer, and thus stand as promising remedies in treating such diseases. CAS No. 1133-45-5. Molecular formula: C8H16O6. Mole weight: 208.21. | |
| 2',3'-Di-O-methylguanosine | 2',3'-Di-O-methylguanosine, a remarkable biomedicine, takes center stage in the exploration and innovation of antiviral therapeutics, combating an array of viral afflictions. Its indispensability arises from its pivotal contribution to nucleic acid synthesis, with a particularly noteworthy involvement in the assembly of messenger RNA (mRNA) entities. By unraveling the intricate intricacies of viral replication and advancing novel curative measures, this product unfurls new vistas for scientific inquiry and medical breakthroughs. Molecular formula: C12H17N5O5. Mole weight: 311.30. | |
| 2',3'-Di-O-(tert-butyldimethylsilyl)-2'-deoxycytidine | 2',3'-Di-O-(tert-butyldimethylsilyl)-2'-deoxycytidine is an intermediate for biosynthesis of cholyl-CoA and oligodeoxyribonucleotides. Alternative Names: 3',5'-Bis-O-tert-butyldimethylsilyl-2'-deoxycytidine; 2'-Deoxy-3',5'-bis-O-[(1,1-dimethylethyl)dimethylsilyl]cytidine. CAS No. 51549-29-2. Molecular formula: C21H41N3O4Si2. Mole weight: 455.74. | |
| 2',3'-Dithiouridine | 2',3'-Dithiouridine is a compound useful in organic synthesis. Alternative Names: 2',3'-DITHIOURIDINE; 156592-92-6; 1-[(2R,3S,4R,5R)-5-(hydroxymethyl)-3,4-bis(sulfanyl)oxolan-2-yl]pyrimidine-2,4-dione; DTXSID40570934; AKOS030241904. CAS No. 156592-92-6. Molecular formula: C9H12N2O4S2. Mole weight: 276.33. | |
| 2,3-ene-glucose | 2,3-ene-glucose, an anomalous form of glucose possessing a carbon-carbon double bond between positions 2 and 3, exhibits intriguing prospects as a building-block in the synthesis of diverse drugs and bioactive agents. The singular structure of this saccharide also presents opportunities for investigating glucose metabolism and devising innovative therapeutic strategies for managing metabolic ailments, such as diabetes. Alternative Names: (4R,5R,E)-2,3,4,5,6-pentahydroxyhex-2-enal. Molecular formula: C6H10O6. Mole weight: 178.14. | |
| 2'- /3'-Fluo-AHC-5'-AMP | 2'- /3'-Fluo-AHC-5'-AMP is a fluorescent analogue of 5'-AMP, which is used as a calibrator in phosphodiesterase (PDE) assays. Alternative Names: 2'- / 3'- O- (6- [Fluoresceinyl]aminohexylcarbamoyl)adenosine- 5'- O- monophosphate, sodium salt. Grades: ≥ 95% by HPLC. Molecular formula: C38H38N7O14P (free acid). Mole weight: 847.7 (free acid). | |
| 2',3'-Ipr-Guo | 2',3'-Ipr-Guo represents an invaluable asset for illuminating the complex intricacies of purinergic receptor functionality and signaling within an array of medical contexts. From tumorigenesis to inflammation and neurodegenerative disease, this biomedical product boasts a potent and selective agonism toward the P2Y11 receptor, thus imparting a keen ability to modulate immune response and stymie inflammation. Ideal for probing into the fascinating universe of biomedicine and pharmacology. CAS No. 362-76-6. Molecular formula: C13H17N6O6. Mole weight: 323.3. | |
| 2',3'-Ipr-Ino | 2',3'-Ipr-Ino, an extraordinary biomedicine, exhibits profound efficacy in combating specific diseases. Renowned for its ability to combat RNA viruses, it has undergone comprehensive scrutiny and has consistently illustrated remarkable potential in suppressing the replication of diverse RNA viruses. Alternative Names: 2',3'-O-Isopropylideneinosine; 2',3'-Isopropylideneinosine; 2',3'-o-(1-methylethylidene)inosine. Grades: 98%. CAS No. 2140-11-6. Molecular formula: C13H16N4O6. Mole weight: 308.29. | |
| 2',3'-Isopropylidene-5-hydroxyuridine | 2',3'-Isopropylidene-5-hydroxyuridine, a potent pharmaceutical agent approved for treating viral infections such as hepatitis B and C shows exceptional effectiveness in curtailing viral replication by confining the virus count in the corpus. Numerous in vitro as well as in vivo studies have substantiated the antiviral potential of this product, which presents it as a hopeful subject for viral infections treatment. Alternative Names: 2',3'-O-isopropylidene-5-hydroxyuridine; 5-hydroxy-1-((3aR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione; 5-Hydroxy-2',3'-O-(1-methylethylidene)uridine; 5-Hydroxy-2',3'-O-isopropylideneuridine. Grades: ≥95%. CAS No. 20406-82-0. Molecular formula: C12H16N2O7. Mole weight: 300.26. | |
| 2',3'-Isopropylidene Adenosine-5'-carboxylic Acid | Used in the preparation of nucleosides as adenosine A3 receptor agonists. Alternative Names: 1-(6-Amino-9H-purin-9-yl)-1-deoxy-2,3-O-(1-methylethylidene)-β-D-ribofuranuronic Acid; NSC 143678. Grades: 98 %. CAS No. 19234-66-3. Molecular formula: C13H15N5O5. Mole weight: 321.29. | |
| 2',3'-Isopropylidene α-Ribavirin | Protected Ribavirin impurity B. Uses: Protected ribavirin impurity b. Alternative Names: 1-(2',3'-Isopropylidene-α-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide. CAS No. 69313-80-0. Molecular formula: C11H16N4O5. Mole weight: 285.27. | |
| 2',3'-Isopropylidenecytidine | 2',3'-Isopropylidenecytidine is an intermediate in synthesizing 5-Hydroxymethylcytidine-13CD2, an analogue of 5-Hydroxymethylcytidine which is a product in DNA hydroxymethylation. Alternative Names: 2',3'-O-Isopropylidenecytidine; 2',3'-O-(1-Methylethylidene)cytidine; Furo[3,4-d]-1,3-dioxole Cytidine Derivative; NSC 520039. CAS No. 362-42-5. Molecular formula: C12H17N3O5. Mole weight: 283.28. | |
| 2-(3-Methyl-n-butylidenehydrazino)adenosine | 2-(3-Methyl-n-butylidenehydrazino)adenosine, a powerful adenosine receptor agonist, has garnered much attention within the biomedical industry due to its ability to isolate and scrutinize the precise role that adenosine plays in various physiological processes, such as cardiovascular functions, immunomodulation, and inflammation. Its potential as a potential therapeutic agent for a plethora of illnesses, including cancer, asthma, and ischemic heart disease, has been investigated extensively; all of which due to its ability to skillfully manipulate adenosine receptor signaling pathways. Alternative Names: Adenosine, 2-[(3-methylbutylidene)hydrazino]-; (2R,3R,4S,5R)-2-[6-amino-2-[(2E)-2-(3-methylbutylidene)hydrazinyl]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol; 2-[(2E)-2-(3-Methylbutylidene)hydrazino]adenosine; 2-(3-Methyl-n-butylidene hydrazino)adenosine. Grades: ≥95%. CAS No. 144348-17-4. Molecular formula: C15H23N7O4. Mole weight: 365.39. | |
| 2',3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt | 2',3'-(N-Methylanthraniloyl)-adenosine-5'-monophosphate triethylammonium salt, an indispensable compound in biomedical research, serves as a remarkable asset in exploring intricate intracellular calcium ion signaling pathways and evaluating the impact of drugs on cellular functions. The significance of this product resides in its pivotal contribution to the advancement of groundbreaking therapies targeting conditions linked to aberrant calcium signaling. Molecular formula: C18H21N6O8P·xC6H15N. Mole weight: 480.37 (free acid). | |
| 2'/3'-(N-Methylanthraniloyl)-adenosine-5'-triphosphate triethylammonium salt | The 2'/3'-(N-Methylanthraniloyl)-adenosine-5'-triphosphate triethylammonium salt, an essential compound utilized in the biomedical sector, exhibits its significance as a robust fluorescent probe for comprehensive investigations into diverse biological phenomena. Researchers predominantly employ this prolific product to delve into enzymatic reactions, nucleotide binding, and ATPase activity. Furthermore, it facilitates the exploration of drug influences, receptor-ligand interplays, and signal transduction pathways associated with manifold maladies. Alternative Names: (2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-4-hydroxy-5-(((hydroxy((hydroxy(phosphonooxy)phosphoryl)oxy)phosphoryl)oxy)methyl)tetrahydrofuran-3-yl 4-(methylamino)benzoate; 175737-77-6. CAS No. 175737-77-6. Molecular formula: C18H23N6O14P3·xC6H16N. Mole weight: 640.33 (free acid). | |
| 2',3'-O-(1-Methylethylidene)-5'-thio-adenosine 5'-Acetate | 2',3'-O-(1-Methylethylidene)-5'-thio-adenosine 5'-Acetate is an intermediate in synthesizing Decarboxylated S-Adenosylmethionine Sulfate Salt, a substrate that is involved in the biosynthesis of polyamines including spermidine, spermine, and thermospermine. Alternative Names: Furo[3,4-d]-1,3-dioxole Adenosine Derivative; S-(((3aS,4S,6R,6aR)-6-(6-Amino-9H-purin-9-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl) Ethanethioate. CAS No. 84365-04-8. Molecular formula: C15H19N5O4S. Mole weight: 365.41. | |
| 2',3'-O-(1-Methylethylidene)-6-thio-5'-inosinic Acid Bis(1,1-Dimethylethyl) Ester | 2',3'-O-(1-Methylethylidene)-6-thio-5'-inosinic Acid Bis(1,1-Dimethylethyl) Ester is an intermediate in the synthesis of 6-Thioinosine Phosphate, a metabolite of 6-Mercaptopurine. CAS No. 1375103-71-1. Molecular formula: C21H33N4O7PS. Mole weight: 516.55. | |
| 2,3-O-(1-Methylethylidene)-β-L-erythropentopyranosid-4-ulose Methyl Ether | As an intermediate in the synthesis of Neopatulin, a mycotoxic substance, 2,3-O-(1-Methylethylidene)-β-L-erythropentopyranosid-4-ulose Methyl Ether is produced by Penicillium and Aspergillus species. Alternative Names: β-L-erythro-Pentopyranosid-4-ulose, methyl 2,3-O-(1-methylethylidene)-; L-erythro-Pentopyranosid-4-ulose, methyl 2,3-O-isopropylidene-, β-; Methyl 2,3-O-(1-methylethylidene)-β-L-erythro-pentopyranosid-4-ulose. CAS No. 22596-25-4. Molecular formula: C9H14O5. Mole weight: 202.20. | |
| 2'/3'-O-Acetyl ADP Ribose, Disodium Salt(A mixture of 2' and 3'-O-Acetyl ADP Ribose) | 2'/3'-O-Acetyl ADP Ribose, are the metabolites produced from NAD as a product of sirtuin-mediated protein deacetylation. Alternative Names: Adenosine 5'-(trihydrogen diphosphate) P'→5-Ester with D-ribose 2-Acetate Sodium Salt (1:2). Grades: 95%. CAS No. 1312013-29-8. Molecular formula: C17H23N5Na2O15P2. Mole weight: 645.32. | |
| 2',3'-O-Bis(tert-butyldimethylsilyl)-5'-O-(dimethoxytrityl)uridine | 2',3'-O-Bis(tert-butyldimethylsilyl)-5'-O-(dimethoxytrityl)uridine, an indispensable entity in biomedical research and the pharmaceutical sector, assumes a pivotal role. It serves as a critical element in the construction of altered nucleosides, holding great promise in the creation of antiviral medications and potential remedies for diverse ailments. Alternative Names: 2',3'-Bis-O-tert-butyldimethylsilyl-5'-O-DMT-uridine; 5'-O-(dimethoxytrityl)-2',3'-bis(tert-butyldimetylsilyl)uridine. Grades: ≥95%. CAS No. 82444-76-6. Molecular formula: C42H58N2O8Si2. Mole weight: 775.09. | |
| 2,3-O-Carbonyl-4,6-O-isopropylidene-a-D-mannopyranoside | 2,3-O-Carbonyl-4,6-O-isopropylidene-a-D-mannopyranoside, a powerful chemical compound, finds its application in drug discovery. Its glycoside properties come in handy in altering the biological activity of multiple compounds, making it a valuable tool in the field of medicine. Its potential in treating viral diseases, bacterial infections, and cancer makes it a promising drug candidate. Molecular formula: C10H14O7. Mole weight: 246.21. | |
| 2,3-O-Carbonyl-a-D-mannopyranose | 2,3-O-Carbonyl-a-D-mannopyranose, a highly valuable compound extensively utilized in the biomedicine industry, plays a pivotal role in the synthesis of diverse drugs targeting prominent diseases including diabetes, cancer, and cardiovascular disorders. Through its distinctive structure and properties, this compound facilitates the creation of ground-breaking pharmaceuticals that exhibit enhanced efficacy and precise target specificity. CAS No. 76548-27-1. Molecular formula: C7H10O7. Mole weight: 206.15. | |
| 2,3-O-Cyclohexylidene-1,6-bis-O-(phenylmethyl)-D-myo-inositol | 2,3-O-Cyclohexylidene-1,6-bis-O-(phenylmethyl)-D-myo-inositol is an intermediate in the synthesis of phosphonate derivatives of myo-inositol for use in biochemical studies of inositol-binding proteins. Alternative Names: Spiro[1,3-benzodioxole-2,1'-cyclohexane], D-myo-inositol deriv. CAS No. 152697-26-2. Molecular formula: C26H32O6. Mole weight: 440.53. | |
| 2,3-O-Cyclohexylidene-b-D-ribofuranose | 2,3-O-Cyclohexylidene-b-D-ribofuranose, a compound of immense importance in the field of biomedicine, displays remarkable potential for the development of anti-cancer medications owing to its robust anti-tumor properties. Moreover, it assumes a pivotal position in the creation of nucleoside analogues and carbohydrate-based therapeutic agents, endowing it with significant utility in the treatment of diverse ailments ranging from viral infections to diabetes and cardiovascular afflictions. Alternative Names: 2,3-O-Cyclohexylidene-β-D-ribofuranose; β-D-Ribofuranose, 2,3-O-cyclohexylidene-; (3a'R,4'R,6'R,6a'R)-6'-(hydroxymethyl)tetrahydrospiro[cyclohexane-1,2'-furo[3,4-d][1,3]dioxol]-4'-ol. CAS No. 177414-91-4. Molecular formula: C11H18O5. Mole weight: 230.26. | |
Our database is helping our users find suppliers everyday.
